Innovative Industrial Properties Announces Strategic and Diversifying $270 Million Investment in Life Science Real Estate Platform
The investment (the 'Investment,' 'Transaction,' or 'Investment Transaction') is comprised of two discrete investments that together are expected to earn a weighted average interest rate of greater than 14% per annum:
A $100 million commitment to a revolving credit facility ('RCF') with an initial term of three years, which can be extended for an additional 12 months upon payment of an extension fee. The RCF will be fully funded upfront, with closing subject to customary approvals.
A commitment to purchase up to $170 million of preferred stock ('Preferred Stock') of IQHQ. The Preferred Stock investment is expected to be funded in multiple tranches between the third quarter of 2025 and the second quarter of 2027, subject to extensions at the option of IQHQ.
Warrants in IQHQ, subject to the satisfaction of certain funding milestones of the Preferred Stock.
'We are excited to announce our first expansion outside of cannabis with this highly accretive transaction that diversifies our business and accelerates IIP's growth trajectory,' said Alan Gold, Executive Chairman of IIP. 'While we remain committed to the cannabis industry, this transaction leverages our team's deep historical experience in the life science industry, which we believe will benefit IIP shareholders via earnings growth and as participants in the life science secular recovery that I believe is underfoot. The transaction is structured with key tenets that include strong current income over the life of the investment, paired with future upside opportunities via warrants and the potential to acquire life science real estate facilities directly from IQHQ.'
Strategic and Financial Benefits of the Transaction:
Highly Accretive Transaction
Investment is expected to be highly accretive to AFFO per share based on the weighted average interest rate payable (which is expected to exceed 14% per annum).
Senior Position in the Capital Stack Offers Strong Risk-Adjusted Return Opportunity
Investment is comprised of the RCF and Preferred Stock, which both sit senior to all common equity in IQHQ and at a material discount to replacement cost of the underlying assets.
Enhanced Portfolio Diversification by Sector, Tenant and Investment Type
Pro forma for the closing of the Transaction, IIP will diversify its holdings and reduce current sector and tenant concentration. IIP believes these measures further improve its financial outlook.
Rental revenues from regulated cannabis facilities are expected to decrease to 88% of the Company's total revenues on an adjusted basis as of June 30, 2025.
Improved Cost of Capital Potential
The enhanced scale and diversification that is expected from the Transaction may support a lower cost of equity and debt capital for IIP and further accelerate its growth.
IIP has Expertise in Capitalizing on Long-Term Secular Tailwinds in Life Sciences
IIP management team has decades of combined experience in the life science real estate industry through its prior role leading top-performing publicly-traded life science REITs.
Noteworthy experience includes Alan Gold's role as Founder and CEO of BioMed Realty Trust, which held its IPO in 2004 and culminated in a successful $8 billion sale to Blackstone in 2016.
According to Pitchbook, 2025 fundraising for the life science industry is on track to achieve the highest level since 2021, which was the all-time high.
According to CBRE, deliveries of new life science real estate are expected to meaningfully decrease during the term of the Transaction, which IIP believes will contribute to strength in the underlying sector and Investment.
The Company expects to fund the RCF with a combination of cash on hand and draws from the Company's revolving credit facility. The Company expects to fund the Preferred Stock investment with cash on hand, draws from the Company's revolving credit facility and potential proceeds from future financing activities. The Investment Transaction is expected to close in the third quarter of 2025, subject to the satisfaction of customary closing conditions.
About IQHQ
IQHQ, Inc. is a life science focused real estate company founded in 2019 to meet the growing industry needs through the acquisition, development, redevelopment, leasing and management of life science assets.
About Innovative Industrial Properties
Innovative Industrial Properties, Inc. is a real estate investment trust (REIT) focused on the acquisition, ownership and management of specialized industrial properties, and, pro forma for this contemplated transaction, life science real estate. Additional information is available at www.innovativeindustrialproperties.com.
This press release contains statements that IIP believes to be 'forward-looking statements' within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than historical facts are forward-looking statements. When used in this press release, words such as IIP 'expects,' 'intends,' 'plans,' 'estimates,' 'anticipates,' 'believes' or 'should' or the negative thereof or similar terminology are generally intended to identify forward-looking statements, and they include, but are not limited to, statements regarding the size, structure, and timing of the Investment Transaction; its expected yield and accretive impact; the satisfaction of closing conditions; anticipated effects on the Company's financial results, including AFFO per share; expected improvements in cost of capital and future growth prospects; anticipated funding sources for the Preferred Stock investment; the outlook for the life science industry; and potential upside from the receipt of warrants. These forward-looking statements are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied by, such statements. Factors that could cause results to differ from those projected or assumed in any forward-looking statement include, but are not limited to, the risk factors discussed in the Company's most recent Annual Report on Form 10-K for the year ended December 31, 2024, as updated by the Company's subsequent reports filed with the Securities and Exchange Commission. Investors should not place undue reliance upon forward-looking statements. IIP disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Here's How You Can Earn $100 In Passive Income By Investing In Alexander & Baldwin Stock
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Alexander & Baldwin Inc. (NYSE:ALEX) is a real estate investment trust that owns, operates and manages commercial real estate in Hawaii. It is the state's largest owner of grocery-anchored, neighborhood shopping centers. It will report its Q3 2025 earnings on Oct. 23. Wall Street analysts expect the company to post EPS of $0.29, up from $0.27 in the prior-year period. According to data from Benzinga Pro, quarterly revenue is expected to be $51.67 million, down from $61.94 million a year earlier. The 52-week range of Alexander & Baldwin stock price was $15.70 to $20.11. Alexander & Baldwin's dividend yield is 4.94%. It paid $0.90 per share in dividends during the last 12 months. Don't Miss: The same firms that backed Uber, Venmo and eBay are investing in this pre-IPO company disrupting a $1.8T market — $100k+ in investable assets? – no cost, no obligation. The Latest On Alexander & Baldwin The company on July 24 announced its Q2 2025 earnings, posting EPS of $0.35, compared to the consensus estimate of $0.08, and revenues of $51.70 million, compared to the consensus of $51.35 million, as reported by Benzinga. 'Our high-quality portfolio continues to perform well, and as a result, we are raising our guidance. I am equally pleased with the team's execution of our internal growth strategy – making meaningful progress constructing our build-to-suit warehouse on Maui and signing another build-to-suit lease on Oahu in the second quarter,' said CEO Lance Parker. The company raised its full-year 2025 guidance, now expecting FFO per diluted share to be between $1.35 and $1.40. Trending: 'Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. How Can You Earn $100 Per Month As An Alexander & Baldwin Investor? If you want to make $100 per month — $1,200 annually — from Alexander & Baldwin dividends, your investment value needs to be approximately $24,291, which is around 1,332 shares at $18.23 each. Understanding the dividend yield calculations: When making an estimate, you need two key variables — the desired annual income ($1,200) and the dividend yield (4.94% in this case). So, $1,200 / 0.0494 = $24,291 to generate an income of $100 per month. You can calculate the dividend yield by dividing the annual dividend payments by the current price of the dividend yield can change over time. This is the outcome of fluctuating stock prices and dividend payments on a rolling basis. For instance, assume a stock that pays $2 as an annual dividend is priced at $50. Its dividend yield would be $2/$50 = 4%. If the stock price rises to $60, the dividend yield drops to 3.33% ($2/$60). A drop in stock price to $40 will have an inverse effect and increase the dividend yield to 5% ($2/$40). In summary, income-focused investors may find Alexander & Baldwin stock an attractive option for making a steady income of $100 per month by owning 1,332 shares of stock. Read Next: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." Here's , starting today. Image: Shutterstock This article Here's How You Can Earn $100 In Passive Income By Investing In Alexander & Baldwin Stock originally appeared on
Yahoo
2 hours ago
- Yahoo
NYSE Content Advisory: Celebrating Singapore's 60th Anniversary - A Milestone of Progress
NEW YORK, Aug. 7, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) today extends its heartfelt congratulations to the Republic of Singapore on the occasion of its 60th National Day, celebrated annually on August 9th. As a dynamic and forward-looking nation, Singapore has emerged as a vital hub in the global financial landscape, earning widespread recognition for its strong governance, economic resilience, and leadership in innovation. Over the past six decades, Singapore has become not only a regional powerhouse but also a respected voice in the global community, championing collaboration, open markets, and sustainable growth. "On behalf of the entire NYSE community, we wish Singapore a joyous 60th birthday," said Cassandra Seier, Head of International Capital Markets at NYSE. "Singapore's vibrant economy and contribution to the global community is deeply admired. We look forward to continuing our strong connections and fostering even greater collaboration within the interconnected global marketplace." The NYSE proudly celebrates Singapore's achievements and its continued dedication to building a prosperous, inclusive future—both for its citizens and for the international community it so actively engages with. In that same spirit, this fall, the NYSE will bring together leaders, innovators, and members of the international community to explore new ideas and strengthen the collaborative spirit at NYSE International Day. View original content to download multimedia: SOURCE New York Stock Exchange Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Upturn
2 hours ago
- Business Upturn
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Centene Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Centene Corporation (NYSE: CNC) between December 12, 2024 and June 30, 2025, both dates inclusive (the 'Class Period'), of the important September 8, 2025 lead plaintiff deadline. SO WHAT: If you purchased Centene securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Centene class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 8, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period provided investors with material information concerning Centene's expected revenue guidance and adjusted diluted earnings per share ('EPS') for the 2025 fiscal year. Defendants' statements included, among other things, confidence in Centene's enrollment and morbidity rates, as well as strong retention rates in Centene's Medicare business. Defendants provided these overwhelmingly positive statements to investors while simultaneously disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Centene's enrollment and morbidity rates. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the Centene class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. ——————————- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected]
